Behavioral Health Market Insights - Q2 2026

• The U.S. behavioral health market is projected to grow rapidly from ~$95B in 2025 to ~$129B in 2030 at a CAGR of 6.4%. This growth is fueled by a few prevailing factors including an increasing prevalence of behavioral health disorders, rising psychiatric admissions and crisis episodes.
• Over the past several years, behavioral health trends in the U.S. have diverged across key indicators. Autism prevalence and demand for autism therapy services have continued to rise, particularly among children and adolescents, driven by greater awareness, expanded screening, improved diagnostic criteria, and broader access to evidence based treatments such as applied behavior analysis. In contrast, overall mental health prevalence remains elevated, with more than 1 in 5 U.S. adults experiencing mental illness annually, and rates of anxiety, depression, loneliness, and psychological distress staying high or increasing, especially among younger populations. This divergence suggests that while autism related service demand reflects developmental factors, broader behavioral health demand is shaped by social, psychological, and digital stressors.
• Behavioral health demand is increasingly showing up in acute care settings, reinforcing the need for better infrastructure and care coordination tools. Mental health related conditions account for roughly 12.3% of emergency department visits among U.S. adults each year, reflecting both the prevalence of untreated or poorly managed conditions and limited access to outpatient care. Emergency departments are often the default entry point for patients experiencing psychiatric crises, substance related complications, or severe anxiety and depressive episodes. This reliance on high cost, episodic care highlights system inefficiencies and underscores the need for scalable solutions that improve intake, triage, documentation, care coordination, and follow up across behavioral health settings.

Sources: Becker’s Behavioral Health, National Alliance of Mental Illness

• The U.S. autism treatment market was valued at $878 million in 2025 and is projected to expand at a CAGR of 6.3%, reaching nearly $1.2 billion by 2030, driven by rising diagnosis rates and increasing demand for evidence-based behavioral interventions.
• In May 2025, the CDC published the latest data from the Autism and Developmental Disabilities Monitoring Network. In 2022, about 1 in 31 eight-year-old children (3.2%) were identified with autism, up from 1 in 36 in 2020. The increase reflects a combination of factors, including earlier and more consistent screening, expanded access to developmental evaluations, improved diagnostic criteria, and growing awareness among parents, educators, and clinicians.
• As a result, demand for applied behavior analysis (ABA), speech & occupational therapy, and multidisciplinary care models continue to accelerate, accentuating the existing care gap, and placing pressure on provider capacity while creating long-term tailwinds for specialized autism services platforms.
• Researchers at Princeton University and the Simons Foundation recently identified four biologically and clinically distinct autism subtypes, moving away from the traditional single-disorder model. This classification could enable more precise diagnoses and targeted interventions tailored to the specific subtype, rather than a one-size-fits-all approach.
• Pharmaceutical innovation continues to anchor growth in the U.S. autism treatment market, with drug developers focused on managing irritability, hyperactivity, and behavioral dysregulation across both pediatric and adult populations. Late-stage pipeline assets are expected to expand the addressable patient base, while the growing use of digital behavioral therapies is improving treatment consistency and access.

Sources: Becker’s Behavioral Health, National Alliance of Mental Illness